Prism Biolab Co (TSE:206A) Total Liabilities : 円1,025.7 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co Total Liabilities?

Prism Biolab Co's Total Liabilities for the quarter that ended in Sep. 2024 was 円1,025.7 Mil.

Prism Biolab Co's quarterly Total Liabilities increased from Sep. 2023 (円63.41 Mil) to Mar. 2024 (円774.67 Mil) and increased from Mar. 2024 (円774.67 Mil) to Sep. 2024 (円1,025.67 Mil).

Prism Biolab Co's annual Total Liabilities declined from Sep. 2022 (円65.23 Mil) to Sep. 2023 (円63.41 Mil) but then increased from Sep. 2023 (円63.41 Mil) to Sep. 2024 (円1,025.67 Mil).

Prism Biolab Co Total Liabilities Historical Data

The historical data trend for Prism Biolab Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co Total Liabilities Chart

Prism Biolab Co Annual Data

Trend

Sep22

Sep23

Sep24

Total Liabilities

65.23

63.41

1,025.67

Prism Biolab Co Semi-Annual Data
	Sep22	Sep23	Mar24	Sep24
Total Liabilities	65.23	63.41	774.67	1,025.67

Prism Biolab Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Prism Biolab Co's Total Liabilities for the fiscal year that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1019.869	+	(0	+	5.7959999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	1,025.7

Total Liabilities	=	Total Assets (A: Sep. 2024 )	-	Total Equity (A: Sep. 2024 )
	=	4528.566	-	3502.901
	=	1,025.7

Prism Biolab Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1019.869	+	(0	+	5.7959999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	1,025.7

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	4528.566	-	3502.901
	=	1,025.7

Prism Biolab Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Prism Biolab Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555

Website

https://www.prismbiolab.com

Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines